Edition:
United Kingdom

People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

18.25USD
18 Apr 2019
Change (% chg)

$-0.11 (-0.60%)
Prev Close
$18.36
Open
$18.34
Day's High
$18.34
Day's Low
$18.25
Volume
273
Avg. Vol
2,152
52-wk High
$20.00
52-wk Low
$11.30

Munoz, Alain 

Dr. Alain Munoz, Ph.D. has been Independent Member of the Board of Directors at Zealand Pharma A/S since 2007. He served as Director of the Company from 2005 until 2006 when he resigned. Alain Munoz has over 20 years of experience in the pharmaceutical industry at senior management level. Within the Sanofi Group he served as SVP for International development and in Fournier Laboratories as SVP for the Pharmaceutical division. He is Chairman of the Board of Hybrigenics SA and member of the Board of Valneva SE. Moreover, he is adviser to Kurma Biofund and Independent Board Member at Oxthera. Alain Munoz holds an MD in Cardiology and Anaesthesiology from the Hospital Pitie-Salpetriere, Paris. He has numerous publications and has been a member of the scientific committee of the French Drug Agency (ANSM).

Basic Compensation

Total Annual Compensation, DKK 283,000
Restricted Stock Award, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 283,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --